SN
Swati Nandakumar Jagtap
About Swati Nandakumar Jagtap
Data last updated:
Swati Nandakumar Jagtap has 4 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Mannved Pharma Private Limited and Mahud Multi Speciality Hospital & Icu Llp. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Mannved Pharma Private Limited at ₹55.9 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Mannved Pharma Private Limited U24100PN2022PTC207803 | Director | 19 Jan 2022 | 2022 | ₹55.9 Lakh (FY 2025) | Active |
| Aurivexaa International Private Limited U46909PN2026PTC258468 | Director | 29 Jul 2026 | 2026 | – | Active |
| Designated Partner | 25 Feb 2024 | 2019 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Swati Nandakumar Jagtap
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Swati Nandakumar Jagtap
Swati Nandakumar Jagtap has 4 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Mannved Pharma Private Limited and Mahud Multi Speciality Hospital & Icu Llp. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Mannved Pharma Private Limited at ₹55.9 Lakh (FY 2025).
Swati Nandakumar Jagtap is associated with 3 companies as Director and Designated Partner, including Mannved Pharma Private Limited (₹55.9 Lakh), Aurivexaa International Private Limited, Mahud Multi Speciality Hospital & Icu Llp.
Swati Nandakumar Jagtap has expertise in General Business.
Swati Nandakumar Jagtap has 4 years in corporate governance.
By reported revenue, the largest current company of Swati Nandakumar Jagtap is Mannved Pharma Private Limited, with revenue of ₹55.9 Lakh (FY 2025).
Swati Nandakumar Jagtap currently holds positions at 3 companies: Mannved Pharma Private Limited (₹55.9 Lakh), Aurivexaa International Private Limited, Mahud Multi Speciality Hospital & Icu Llp.